Trends in replacement of pacemaker leads in the Netherlands: A long‐term nationwide follow‐up study

Vries, Laura M. de; Leening, Maarten J.G.; Dijk, W.A.; Hooijschuur, C.A.M.; Stricker, Bruno H. Ch.; Hemel, Norbert M. van

doi:10.1111/pace.13371

Cited by 4 publications

(2 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thirdly, in the long-term, PM leads are prone to failure such as lead fracture or insulation break. The incidence of chronic lead failure is about 1-4% and the median time to failure 5 to 7 years [6,[17][18][19][20]. Lastly, lead dislodgement in conventional PM systems is not uncommon and occurs in 1.6% of all PM patients on average [21].…”

mentioning

confidence: 99%

State of the art: leadless ventricular pacing

Steinwender

Lercher

Schukro

et al. 2019

J Interv Card Electrophysiol

View full text Add to dashboard Cite

Background Cardiac pacing has been shown to improve quality of life and prognosis of patients with bradycardia for almost 60 years. The latest innovation in pacemaker therapy was miniaturization of generators to allow leadless pacing directly in the right ventricle. There is a long history and extensive experience of leadless ventricular pacing in Austria. However, no recommendations of national or international societies for indications and implantation of leadless opposed to transvenous pacing systems have been published so far. Results A national expert panel of skilled implanters gives an overview on the two utilized leadless cardiac pacing systems and highlights clinical advantages as well as current knowledge of performance and complication rates of leadless pacing. Furthermore, a national consensus for Austria is presented, based on recent studies and current know-how, specifically including indications for leadless pacing, management of infection, suggestions for qualification, and training of the operators and technical standards. Conclusions Leadless pacing systems can be implanted successfully with a low complication rate, if suggestions for indications and technical requirements are followed. Condensed abstract An overview of the two utilized leadless cardiac pacing systems is given, specifically highlighting clinical advantages as well as current knowledge of performance and complication rates. Furthermore, a national consensus for Austria is presented, specifically including indications for leadless pacing, management of infection, and suggestions for qualification and technical standards.

show abstract

mentioning

confidence: 99%

State of the art: leadless ventricular pacing

Steinwender

Lercher

Schukro

et al. 2019

J Interv Card Electrophysiol

View full text Add to dashboard Cite

show abstract

“…Complex larger devices like defibrillators and resynchronizing devices in children and young adults are more frequently associated with endocarditis [28]. Infections were the reason for 8.8% of all lead extractions [29]. There are no specific reports that suggest a higher incidence of pacing lead infections in patients with Fontan circulation.…”

Section: Discussionmentioning

confidence: 99%

Endocardial transvenous pacing in patients with surgically palliated univentricular hearts: A review on different techniques, problems and management

Umamaheshwar

Singh

Sivakumar

2019

Indian Pacing and Electrophysiology Journal

View full text Add to dashboard Cite

Fontan surgery and its modifications have improved survival in various forms of univentricular hearts. A regular atrial rhythm with atrioventricular synchrony is one of the most important prerequisite for the long-term effective functioning of this preload dependent circulation. A significant proportion of these survivors need various forms of pacing for bradyarrhythmias, often due to sinus nodal dysfunction and sometimes due to atrioventricular nodal block. The diversion of the venous flows away from the cardiac chambers following this surgery takes away the simpler endocardial pacing options through the superior vena cava. The added risks of thromboembolism associated with endocardial leads in systemic ventricles have made epicardial pacing as the procedure of choice. However challenges in epicardial pacing include surgical adhesions, increased pacing thresholds leading to early battery depletion and frequent lead fractures. When epicardial pacing fails, endocardial lead placement is equally challenging due to lack of access to the cardiac chambers in Fontan circulation. This review discusses the univentricular heart morphologies that may warrant pacing, issues about epicardial pacing, different techniques for endocardial pacing in patients with disconnected superior vena cava, pacing in different modifications of Fontan surgeries, issues of systemic thromboembolism with endocardial leads, atrioventricular valve regurgitation attributed to pacing leads and device infections. In a vast majority of patients following Glenn shunt and Senning surgery, an epicardial pacing and lead replacement is always feasible though technically very difficult. This article highlights the different options of transatrial and transventricular endocardial pacing.

show abstract